BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 3357485)

  • 1. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH; Goldstein D
    J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
    Hoover RK; Toews ML
    J Pharmacol Exp Ther; 1989 Oct; 251(1):63-70. PubMed ID: 2795471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
    Thompson AK; Fisher SK
    J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
    Fisher SK; Snider RM
    Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD; Vaishnav AA; Mash DC
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular distribution of functional M(1) -muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells.
    Uwada J; Anisuzzaman AS; Nishimune A; Yoshiki H; Muramatsu I
    J Neurochem; 2011 Sep; 118(6):958-67. PubMed ID: 21740440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE; Abdel-Latif AA
    Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequestration of muscarinic cholinergic receptors in permeabilized neuroblastoma cells.
    Slowiejko DM; Levey AI; Fisher SK
    J Neurochem; 1994 May; 62(5):1795-803. PubMed ID: 8158129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbachol on rat Sertoli cell proliferation and muscarinic acetylcholine receptors regulation: an in vitro study.
    Lucas TF; Avellar MC; Porto CS
    Life Sci; 2004 Aug; 75(14):1761-73. PubMed ID: 15268975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization and characterization of atrial muscarinic acetylcholine receptors in sucrose monolaurate.
    Rinken A; Haga T
    Arch Biochem Biophys; 1993 Feb; 301(1):158-64. PubMed ID: 8442658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.